Viral Vector, Non-Viral Vector and Gene Therapy Manufacturing market 2022 – Industry Growth by 2035
Over the past few years, cell and gene therapies have gained significant popularity owing to their therapeutic potential.
josephmorale 
In fact, more than 20 genetically modified therapies have already been approved, which has resulted in the increase in demand for vectors, which have proven to be highly efficient for the delivery of genetic material to the targeted area. In order to cater to the growing demand, several companies are offering diverse range of services for vector and gene therapy manufacturing.
By 2035, the financial opportunity within the viral vector manufacturing, non-viral vector manufacturing and gene therapy manufacturing market has been analyzed across the following segments:
- Scale of Operation
- Lab
- Clinical
- Commercial
- Type of Vectors
- AAV
- Adenoviral
- Lentiviral
- Retroviral
- Plasmid DNA
- Other Vectors
- Application Area
- Gene Therapy
- Cell Therapy
- Vaccines
- Therapeutic Area
- Oncological Disorders
- Rare Disorders
- Neurological Disorders
- Sensory Disorders
- Metabolic Disorders
- Musco-skeletal Disorders
- Blood Disorders
- Immunological Diseases
- Others
- Geographical Regions
- North America
- Europe
- Asia Pacific
- Latin America
- MENA
- Rest of the World
The “Viral Vector, Non-Viral Vector and Gene Therapy Manufacturing Market (5th Edition), 2022-2035” report features the following companies, which we identified to be key players in this domain:
- Advanced BioScience Laboratories
- Aldevron
- Audentes Therapeutics
- BioNTech Innovative Manufacturing
- BioReliance
- Biovian
- bluebird bio
- Cell and Gene Therapy Catapult
- Celonic
- Centre for Process Innovation
- Cobra Biologics
- Emergent BioSolutions
- FinVector
- FUJIFILM Diosynth Biotechnologies
- Kaneka Eurogentec
- Lonza
- MeiraGTx
- MolMed
- Novasep
- Orchard Therapeutics
- Oxford BioMedica
- Richter-Helm
- Sanofi
- Spark Therapeutics
- Thermo Fisher Scientific
- uniQure
- Vibalogics
- Vigene Biosciences
- VIVEbiotech
- Wuxi AppTech
Table of Contents
- Preface
- Executive Summary
- Introduction
- Viral Vector and Gene Therapy Manufacturers (Industry Players): Market Landscape
- Plasmid DNA and Gene Therapy Manufacturers (Industry Players): Market Landscape
- Vector And Gene Therapy Manufacturers (Non-Industry Players): Market Landscape
- Vector And Gene Therapy Manufacturing Technologies: Market Landscape
- Company Competitiveness Analysis
- Vector And Gene Therapy Manufacturers in North America
- Vector And Gene Therapy Manufacturers in Europe
- Vector And Gene Therapy Manufacturers in Asia-Pacific
- Other Key Players
- Recent Partnerships
- Recent Expansions
- Strategic Partner Analysis
- Emerging Vectors
- Key Insights
- Cost Price Analysis
- Capacity Analysis
- Demand Analysis
- Market Sizing and Opportunity Analysis
- Porter’s Five Forces Analysis
- Key Drivers and Challenges
- Survey Analysis
- Concluding Remarks
- Executive Insights
To view more details on this report, click on the link:
You may also be interested in the following titles:
You may also like to learn what our experts are sharing in Roots educational series:
|
Smart pharmaceutical and healthcare labels: Lets trace medicines from its origin |
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
